EDIT vs J
Editas Medicine Inc (EDIT) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
J does not have a complete income-statement cache yet.
EDIT currently screens at market cap $375.2M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the EDIT and J stock pages for the full models.
Not investment advice.